Jing Peng

发表

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors

Jane Fridlyand, Antoni Ribas, Timothy R. Wilson, 2012, Nature.

CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia

Yan Tang, Sang H. Lee, Yan Tang, 2005, Clinical Cancer Research.

Pharmacokinetic drivers of toxicity for basic molecules: strategy to lower pKa results in decreased tissue exposure and toxicity for a small molecule Met inhibitor.

Kevin A Ford, D. Sutherlin, M. Merchant, 2013, Toxicology and applied pharmacology.

Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies

Diego Ellerman, Mark Merchant, M. Merchant, 2013, Nature Biotechnology.

Identification and integrated analysis of key differentially expressed circular RNAs in ER-positive subtype breast cancer.

K. Yin, Jing Peng, Yaohui Wang, 2019, Epigenomics.

Estrogen metabolism within the lung and its modulation by tobacco smoke.

T. Veenstra, Xia Xu, M. Slifker, 2013, Carcinogenesis.

Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic–pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inh

M. Merchant, Xingrong Liu, B. Liederer, 2011, Xenobiotica; the fate of foreign compounds in biological systems.

Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.

V. Jordan, S. Sengupta, Jing Peng, 2009, Anti-cancer agents in medicinal chemistry.

Neo-Family History Score Is A Novel Biomarker of Pathological Complete Response, Safety, and Survival Outcomes In Patients With Breast Cancer Receiving Neoadjuvant Platinum-Based Chemotherapy: A Retrospective Analysis of Two Prospective Trials

J Zhang, Jing Peng, Yaohui Wang, 2021, SSRN Electronic Journal.

TIMELESS regulates sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancer

Zhi-gang Zhang, Jing Peng, Shuheng Jiang, 2020, Cell Death & Disease.

Recombinant Interleukin-2 Significantly Augments Activity of Rituximab in Human Tumor Xenograft Models of B-cell Non-Hodgkin Lymphoma

Yan Tang, J. Kunich, B. Jallal, 2007, Journal of immunotherapy.

A synthetic compound, 1,5‐bis(2‐methoxyphenyl)penta‐ 1,4‐dien‐3‐one (B63), induces apoptosis and activates endoplasmic reticulum stress in non‐small cell lung cancer cells

Jian Xiao, Xie Zhang, Huiling Yang, 2012, International journal of cancer.

Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target Therapy

Jing Peng, Yaohui Wang, W. Yin, 2020, Frontiers in Oncology.

The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation.

D. Raha, J. Settleman, T. Wilson, 2014, Cancer research.

Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells.

Yan Tang, Long Yu, Jing Peng, 2015, American journal of cancer research.

Upregulation of microRNA-1 inhibits proliferation and metastasis of breast cancer

Yan Wang, Jing Peng, W. Yin, 2020, Molecular medicine reports.

Association of Neo-Family History Score with pathological complete response, safety, and survival outcomes in patients with breast cancer receiving neoadjuvant platinum-based chemotherapy: An exploratory analysis of two prospective trials

J Zhang, Jing Peng, Yaohui Wang, 2021, EClinicalMedicine.

MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation

Tom T. Chen, A. Jubb, H. Koeppen, 2015, EBioMedicine.

1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer

Xiaofeng Li, Xiaoqian Yang, Na Liu, 2019, Cell cycle.

CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

P. Hegde, Z. Modrušan, James Ziai, 2022, Cell reports. Medicine.

LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication

Jing Peng, Yifan Wu, W. Yin, 2021, Journal of experimental & clinical cancer research : CR.

Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients

Jing Peng, W. Yin, Jinsong Lu, 2021, Frontiers in Oncology.

Estrogen Receptor Pathways and Breast Cancer

V. Jordan, V. Jordan, Jing Peng, 2008 .

SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer

Jing Peng, W. Yin, Jinsong Lu, 2020, Frontiers in Oncology.

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

G. V. Vande Woude, H. Phillips, M. Starovasnik, 2013, Proceedings of the National Academy of Sciences.

Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Antitumor Activity

Genee Y. Lee, R. Neve, P. Carter, 2015, Molecular Cancer Therapeutics.

RedesigningaMonospeci fi cAnti-FGFR 3 Antibody to Add Selectivity for FGFR 2 and Expand Antitumor Activity

R. Neve, S. Marsters, Jarrod R. Tremayne, 2015 .

MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung Adenocarcinoma

D. Flieder, L. Thiberville, J. Sabourin, 2015, PloS one.

Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models

Edward G. Lorenzana, G. Hatzivassiliou, M. Merchant, 2015, Journal of Immunotherapy for Cancer.

Early Changes in Gene Expression Induced by Tobacco Smoke: Evidence for the Importance of Estrogen within Lung Tissue

Gustavo H. Esteves, E. J. Neves, K. Devarajan, 2010, Cancer Prevention Research.

Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics

Jing Peng, W. Yin, Jinsong Lu, 2017, Cancer management and research.

Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer

Yan Wang, Jing Peng, W. Yin, 2019, BMC Cancer.

Estrogen metabolism in the human lung: impact of tumorigenesis, smoke, sex and race/ethnicity

Xia Xu, M. Slifker, G. Ma, 2017, Oncotarget.

Predictive value of lncRNA LOC100505851 in breast cancer in the neoadjuvant setting.

Jing Peng, Yaohui Wang, W. Yin, 2021, Gland surgery.

Synthesis and crystal structure of chalcones as well as on cytotoxicity and antibacterial properties

Xiaokun Li, G. Liang, Yuepiao Cai, 2012, Medicinal Chemistry Research.

Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells.

V. Jordan, Jing Peng, 2009, International journal of oncology.

Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G 0 / G 1 cell cycle arrest in SKBr 3 breast cancer cells

V. Jordan, Jing Peng, 2022 .

Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex

Ziqiang Yang, Yu-xiang Fang, H. Zhu, 2019, Journal of experimental & clinical cancer research : CR.

Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab

M. Merchant, E. Filvaroff, I. Nijem, 2013, Molecular Cancer Therapeutics.

Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer

Yan Wang, Jing Peng, W. Yin, 2019, BMC Cancer.

The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation.

D. Raha, J. Settleman, T. Wilson, 2014, Cancer research.

Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer

S. Sengupta, Jing Peng, V. C. Jordan, 2013 .